FXR is a major regulator of BA metabolism and is involved in lipid and glucose metabolism.138 Different non-BA FXR agonists like tropifexor,139 cilofexor,140 and nidufexor141,142 have been tested in NAFLD and were proved to reduce liver fat content. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.